JP2003513942A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513942A5
JP2003513942A5 JP2001536204A JP2001536204A JP2003513942A5 JP 2003513942 A5 JP2003513942 A5 JP 2003513942A5 JP 2001536204 A JP2001536204 A JP 2001536204A JP 2001536204 A JP2001536204 A JP 2001536204A JP 2003513942 A5 JP2003513942 A5 JP 2003513942A5
Authority
JP
Japan
Prior art keywords
composition
growth factor
vector
peptide
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001536204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513942A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/030345 external-priority patent/WO2001034208A1/en
Publication of JP2003513942A publication Critical patent/JP2003513942A/ja
Publication of JP2003513942A5 publication Critical patent/JP2003513942A5/ja
Pending legal-status Critical Current

Links

JP2001536204A 1999-11-05 2000-11-03 インビボ遺伝子送達による心血管疾患を処理するための技術および組成物 Pending JP2003513942A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43515699A 1999-11-05 1999-11-05
US09/435,156 1999-11-05
US60908000A 2000-06-30 2000-06-30
US09/609,080 2000-06-30
PCT/US2000/030345 WO2001034208A1 (en) 1999-11-05 2000-11-03 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery

Publications (2)

Publication Number Publication Date
JP2003513942A JP2003513942A (ja) 2003-04-15
JP2003513942A5 true JP2003513942A5 (cg-RX-API-DMAC7.html) 2007-12-20

Family

ID=27030448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001536204A Pending JP2003513942A (ja) 1999-11-05 2000-11-03 インビボ遺伝子送達による心血管疾患を処理するための技術および組成物

Country Status (10)

Country Link
EP (1) EP1225921A1 (cg-RX-API-DMAC7.html)
JP (1) JP2003513942A (cg-RX-API-DMAC7.html)
KR (1) KR20020049031A (cg-RX-API-DMAC7.html)
CN (1) CN1433325A (cg-RX-API-DMAC7.html)
AU (1) AU784392B2 (cg-RX-API-DMAC7.html)
CA (1) CA2389524A1 (cg-RX-API-DMAC7.html)
EA (1) EA008538B1 (cg-RX-API-DMAC7.html)
HK (1) HK1048593A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ546670A (cg-RX-API-DMAC7.html)
WO (1) WO2001034208A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1048593A1 (zh) * 1999-11-05 2003-04-11 The Regents Of The University Of California 用於通过体内基因输送治疗心血管疾病的技术和组合物
US20030093147A1 (en) * 2001-11-13 2003-05-15 Ogle Matthew F. Medical devices that stimulate growth factor production
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
PL195457B1 (pl) * 2002-08-05 2007-09-28 Zaklady Farm Polpharma Sa Kaseta ekspresyjna, dwucistronowy wektor plazmidowy, środek farmaceutyczny oraz ich zastosowanie
PL2044199T3 (pl) * 2006-07-25 2013-04-30 Celladon Corp Przedłużony, podawany z prądem krwi, nasierdziowy, wieńcowy wlew wektorów wirusowych na bazie wirusów towarzyszących adenowirusom, zawierający SERCA2a do terapii genowej
AU2008291296B2 (en) * 2007-08-24 2014-02-06 Julius-Maximilians-Universitat Wurzburg Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
CN102046792B (zh) 2008-04-09 2014-12-10 百疗医株式会社 用于提高质粒dna表达的冻干dna制剂
WO2010078624A1 (en) * 2009-01-07 2010-07-15 Vegenics Limited Materials and methods for the treatment of hypertension
KR101006106B1 (ko) * 2009-06-04 2011-01-07 김현태 전·자기장 차단 전열선
US10155099B2 (en) 2009-09-21 2018-12-18 Cook Regentec Llc Method for infusing stem cells
JP6562632B2 (ja) * 2012-02-14 2019-08-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心血管疾患および他の状態のためのパラクリン遺伝子の全身送達および制御された発現
EP2854923B1 (en) 2012-06-05 2019-08-21 Muffin Incorporated Catheter systems and methods useful for cell therapy
CA2926607C (en) 2013-10-22 2018-10-23 Helixmith Co., Ltd Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor
US20210393805A1 (en) * 2018-05-16 2021-12-23 University Of Massachusetts Perfusion-based delivery of recombinant aav vectors for expression of secreted proteins
CN112088017B (zh) 2018-07-19 2023-11-21 赫利世弥斯株式会社 用于裸脱氧核糖核酸基因疗法的经冷冻干燥的药剂学组合物
CN114173863A (zh) * 2019-08-07 2022-03-11 西北大学 用于在心脏中基因递送的材料和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100242A (en) * 1995-02-28 2000-08-08 The Regents Of The University Of California Gene therapies for enhancing cardiac function
US5792453A (en) * 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
BR9806819A (pt) * 1997-01-29 2000-05-09 Cornell Res Foundation Inc Fornecimento de múltiplos locais de vetor adenoviral para a indução de angiogênese.
WO1998050079A2 (en) * 1997-05-06 1998-11-12 The Regents Of The University Of California Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
EP1053025A2 (en) * 1998-02-11 2000-11-22 The Regents of the University of California Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
EP1139751A4 (en) * 1998-12-28 2003-03-19 Arch Dev Corp EFFICIENT AND STABLE -I (IN VIVO) GENE TRANSFER TO CARDIOMYCETS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
HK1048593A1 (zh) * 1999-11-05 2003-04-11 The Regents Of The University Of California 用於通过体内基因输送治疗心血管疾病的技术和组合物

Similar Documents

Publication Publication Date Title
US8178493B2 (en) Method for inducing angiogenesis in a heart of a patient
Mitsos et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials
JP2003519097A5 (cg-RX-API-DMAC7.html)
Bobek et al. Gene therapy of the ischemic lower limb—Therapeutic angiogenesis
US6329348B1 (en) Method of inducing angiogenesis
Boodhwani et al. The future of therapeutic myocardial angiogenesis
Fukuda et al. Angiogenic strategy for human ischemic heart disease: brief overview
JP2002502885A5 (cg-RX-API-DMAC7.html)
CA2289600A1 (en) Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
US7709450B2 (en) Stimulation of vascularization with VEGF-B-186
EA019099B1 (ru) Способ направленной доставки трансгена в миокард пациента с ишемией миокарда
Stegmann New approaches to coronary heart disease: induction of neovascularisation by growth factors
EP1948246B1 (en) Stem cell factor therapy for tissue injury
Sim et al. Therapeutic angiogenesis for coronary artery disease
Symes et al. Angiogenesis: potential therapy for ischaemic disease
CN102755638A (zh) Aggf1在制备促进血管形成的药物中的用途
Isner Manipulating angiogenesis against vascular disease
Webster Therapeutic angiogenesis: a case for targeted, regulated gene delivery
Bashir et al. Angiogenic gene therapy: pre-clinical studies and phase I clinical data
Fedak et al. Angiogenesis: protein, gene, or cell therapy?
Shuman et al. THE GENE THERAPEUTIC CORRECTION OF CORONARY INSUFFICIENCY
JP2005097118A (ja) Hgf遺伝子からなる細胞移植定着促進剤
Ylä-Herttuala Angiogenesis clinical trials
WO2004012775A2 (en) Bicistronic vector encoding a vegf and an fgf, use thereof
Kantor et al. Gene Therapy fo r Myo cardial Angiogenesis: Has It Come of Age?